featured
Ramucirumab With Eribulin vs Eribulin in Locally Recurrent or Metastatic Breast Cancer Previously Treated With Anthracycline and Taxane Therapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Clinical Breast Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Ramucirumab With Eribulin Versus Eribulin in Locally Recurrent or Metastatic Breast Cancer Previously Treated With Anthracycline and Taxane Therapy: A Multicenter, Randomized, Phase II Study
Clin. Breast Cancer 2016 Dec 01;16(6)471-479.e1, DA Yardley, J Reeves, EC Dees, C Osborne, D Paul, F Ademuyiwa, H Soliman, T Guthrie, J Andersen, L Krekow, J Choksi, B Daniel, M Danso, A Favret, S Oommen, A Brufsky, JL Bromund, Y Lin, AB Ibrahim, PD RichardsFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.